Cathie Wood, ARK Investment
6d
24/7 Wall St. on MSNCathie Wood Sours on Tesla and Moderna, but Likes These Stocks InsteadStar portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...
Cathie Wood, chief of Ark Investment Management, usually targets tech stocks with high "disruptive" potential. She frequently ...
TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.
Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF ARKG and Ark Innovation ETF ARKK. The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired ...
Catherine Wood (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into ...
Explore Cathie Wood's latest investment insights on the convergence of artificial intelligence in shaping the future, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results